Form 4: Director Sheila Hopkins Reports Acquisition and Disposal of Prestige Consumer Healthcare Inc. Shares

Sheila Hopkins, a director of Prestige Consumer Healthcare Inc., reports the acquisition of restricted stock units and disposal of common stock on August 6, 2024.

Summary

• On August 6, 2024, Sheila Hopkins, a director of Prestige Consumer Healthcare Inc. (PBH), acquired 2,202 restricted stock units (RSUs) as part of the issuer's director compensation program.
• These RSUs vest on the first anniversary of the grant date and will be settled by delivering one share of PBH common stock for each vested RSU.
• The acquisition price was $0, with the RSUs valued based on a closing stock price of $68.13 on August 6, 2024.
• Hopkins also disposed of 28,029 shares of common stock.
• Following these transactions, Hopkins beneficially owns 28,029 shares of Prestige Consumer Healthcare Inc.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Positives

• The acquisition of restricted stock units aligns the director's interests with the company's performance.

Future Outlook

The restricted stock units vest on the first anniversary of the grant date and will be settled by delivery of common stock upon vesting or certain events such as death, separation, or change in control.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders, such as directors and officers, in their company's stock.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the transactions of company insiders.

Key Dates